Ayr Wellness Inc. (OTCMKTS:AYRWF – Free Report) – Roth Capital equity analysts provided Q1 2025 EPS estimates for Ayr Wellness in a research note published on Wednesday, May 15th. Roth Capital analyst S. Fortune expects the company to report earnings of $0.27 per share in the quarter. Air Wellness’ current consensus estimate for full-year earnings is $0.62 per share. Roth Capital also estimates that Air Wellness’ 2025 second quarter earnings are ($0.25) EPS, 2025 third quarter earnings are ($0.25) EPS, 2025 fourth quarter earnings are ($0.25) EPS, and The company also announced a forecast for FY2025 profit of ($1.02) EPS.
Air Wellness stock price performance
AYRWF stock began trading at $2.70 on Friday. The company’s current ratio is 0.96x, quick ratio is 0.43x, and debt-to-equity ratio is 0.75x. The stock has a market capitalization of $208.63 million, a P/E ratio of -1.28, and a beta of 2.38. The company’s 50 day simple moving average is $2.45 and its 200 day simple moving average is $2.31. Air Wellness has a 12-month low of $0.79 and a 12-month high of $4.09.
Air Wellness (OTCMKTS:AYRWF – Get Free Report) last announced its quarterly earnings results on Wednesday, May 15th. The company reported ($0.27 EPS) for the quarter, which missed analysts’ consensus estimates of ($0.17) by ($0.10). The business had revenue of $118.04 million in the quarter, compared to analyst estimates of $115.45 million. Ayr Wellness had a negative return on equity of 17.36% and a negative net margin of 39.55%.
About Air Wellness
(Get Free Report)
Ayr Wellness Inc operates as a vertically integrated, multi-state cannabis operator that cultivates, manufactures and retails cannabis products and branded cannabis packaged goods. The Company owns and operates a chain of cannabis retail stores under the brand names AYR, Liberty Health Sciences, and The Dispensary.
Related item
Receive news and reviews from Ayr Wellness Daily – Enter your email address below to receive a concise, daily summary of the latest news and analyst ratings for Air Wellness and related companies in MarketBeat.com’s free daily email newsletter.
